The 18 analysts offering 12-month price forecasts for Trulieve Cannabis Corp have a median target of 29.98, with a high estimate of 54.00 and a low estimate of 16.46. The median estimate represents a +133.49% increase from the last price of 12.84.
The current consensus among 18 polled investment analysts is to Buy stock in Trulieve Cannabis Corp. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.00
Reporting Date Nov 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.